PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-706

  1. 120 Posts.
    lightbulb Created with Sketch. 10
    Will be interesting to see if PR addresses the clinical hold, adrenal findings, and 2 mg/kg dosage at the Biotech Summit
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.